This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated PHEX Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-PHEX WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~86.5 kDa | |
| Observed band | 100-110 kDa | |
| Gel | 8–10% | |
| Negative control | siRNA / KO lysate |
| PTM | Glycosylated | |
| Caveat | Heavy glycosylation | |
| Regulation | Complement | |
| Isoform | 1 isoform(s) |
Literature-validated Western blot parameters for PHEX — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.
| Sample / lysate | human PC-3 , Lane 2: human U251 , Lane 3: human A431 , Lane 4: human A549 , After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-PHEX antigen affinity purified polyclonal antibody (A02078) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an ECL Plus Western Blotting Substrate (Catalog # AR1196-200) with Tanon 5200 system. A specific band was detected for PHEX at approximately 100-110 kDa. The expected band size for PHEX is at 86 kDa |
| Gel % | 8–10% |
| Load | 30 ug |
| Transfer | nitrocellulose membrane, 150 mA, 50–90 min |
| Membrane | nitrocellulose |
| Blocking | 5% non-fat milk / TBS, 1.5 h RT |
| Primary antibody | 0.5 µg/mL |
| Primary incubation | overnight at 4 °C |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 |
| Wash | TBS-0.1% Tween, 3 × 5 min |
| Detection | ECL |
| Exposure / imaging | Tanon 5200 |
| Observed band | 100–110 kDa |
PHEX has an 86.5 kDa predicted core but runs at 100-110 kDa on Western blot because its 8 N-linked glycosylation sites add substantial carbohydrate mass.
| single band around 100-110 kDa | mature, fully glycosylated PHEX running well above its 86.5 kDa predicted core mass |
| broad or fuzzy band spanning roughly 90-110 kDa | heterogeneous occupancy across the 8 N-linked glycosylation sites gives a mixed population of glycoforms |
| band closer to 86.5 kDa | corresponds to the unmodified or deglycosylated PHEX backbone rather than the mature membrane-bound form |
| little or no signal from a cytosolic-only prep | PHEX is a single-pass type II membrane protein and needs membrane-compatible lysis to be released and detected |
| band shifts slightly with reducing vs non-reducing conditions | the 5 intrachain disulfide bonds stabilize PHEX's extracellular fold, so incomplete reduction can alter apparent migration |
| predicted core mass (86.5 kDa) | sets the unmodified backbone size before any glycosylation is added |
| N-glycosylation at 8 asparagine sites (e.g., Asn71, Asn238, Asn377, Asn736) | adds carbohydrate mass, pushing the observed band up to roughly 100-110 kDa and potentially broadening it |
| single-pass type II membrane topology | hydrophobic transmembrane segment can cause anomalous SDS-PAGE migration and requires membrane-protein extraction for full solubilization |
| intrachain disulfide bonds (5 pairs stabilizing the extracellular domain) | maintain a compact fold that, if not fully reduced, can shift apparent band position on the gel |
| non-glycosylated or bacterially-expressed recombinant PHEX | lacks the native N-glycans and runs closer to the 86.5 kDa predicted mass, lower than tissue-derived PHEX |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | PHEX is membrane-anchored and is poorly recovered by cytosolic-only lysis | use a membrane-protein extraction buffer with adequate detergent to solubilize the transmembrane protein |
| Band higher than expected | incomplete denaturation of the glycosylated membrane protein or full glycan loading | ensure thorough reduction and denaturation with DTT/β-mercaptoethanol and SDS before loading |
| Band lower than expected | reduced or absent N-glycosylation, as in deglycosylated samples or non-native recombinant expression | compare against a native glycosylated tissue lysate control and note the 86.5 kDa unmodified backbone as reference |
| Broad smear instead of sharp band | heterogeneous glycan occupancy across the 8 N-linked sites | treat lysate with PNGase F to collapse glycoforms toward the 86.5 kDa core band |
| Weak or no signal | PHEX expression is restricted to tissues such as bone, kidney, and teeth, so many cell lines express little of it | use a known PHEX-expressing lysate as a positive control and increase total protein loaded |
| Multiple bands | partial N-glycan occupancy or proteolytic degradation of the membrane protein during extraction | add protease inhibitors during lysis and run a PNGase F-treated sample alongside to distinguish glycoform bands from degradation fragments |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|
| Tissue | Cell type | Level | Evidence | Source |
|---|
Deeper troubleshooting and optimisation questions for PHEX, answered from its protein features.
BosterBio's PHEX antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.
These top-performing anti-PHEX antibodies are extensively cited and rigorously validated, with specificity confirmed through negative-tissue controls and complementary orthogonal methods, ensuring reliable, reproducible Western blot detection of PHEX.
Which to pick: Only one anti-PHEX antibody is catalogued here, A02078, and it comes with an actual Western blot validation image (8% SDS-PAGE), making it the clear default pick—no alternative SKUs are currently listed to compare against.